• Print

JOURNAL SUBMISSION FORM

Title: Atlas of Genetics and Cytogenetics in Oncology and Haematology
URL: http://AtlasGeneticsOncology.org

I- Editor and Publisher

Editor-in-Chief: Jean-Loup Huret, Genetics, University Hospital of Poitiers; Database Director: Philippe Dessen, UMR 1170 INSERM, Gustave Roussy.

Second Editor handling manuscripts: Gajanan V Sherbet, Institute for Molecular Medicine at Huntington Beach California.

Contact Address: Jean-Loup Huret, MD, PhD, 10 rue des Treilles, Masseuil, F-86190 Quinçay, France / Gajanan Sherbet, School of Electrical Electronic and Computer Engineering University of Newcastle upon Tyne, UK

Email: This email address is being protected from spambots. You need JavaScript enabled to view it. ; This email address is being protected from spambots. You need JavaScript enabled to view it. ; This email address is being protected from spambots. You need JavaScript enabled to view it. ; / This email address is being protected from spambots. You need JavaScript enabled to view it.

Phone: +33 5 49 60 46 54

Publisher Address: INIST-CNRS, Catherine Morel, 2,Allée du Parc de Brabois, CS 10130, 54519 Vandoeuvre-lès-Nancy France.

Country of origin: France

e-ISSN: ISSN 1768-3262

Publishing Company: ARMGHM, a non-profit organisation, and by the Institute for Scientific and Technical Information of the French National Center for Scientific Research (INIST-CNRS) since 2008.

Funding: see "Activity reports" of the association in charge of the financial side: http://chromosomesincancer.org/en/activity.html

Sponsoring Organizations, Grants and past Grants: Scientific Societies; European funds; French Ministry of Higher Education and Research; Poitiers University Fundation; French National League against Cancer, etc… see http://atlasgeneticsoncology.org/BackpageAbout.html#GRANTS

II- Publishing Standards

Subject Area: Life Sciences

Publishing Format: electronic format.

Language of Journal: English

Open Access Journal: The Atlas is accessible, free, and may be reproduced under certain conditions (see http://atlasgeneticsoncology.org/BackpageAbout.html#COPYRIGHT and, in this paragraph, the hyperlink toward https://creativecommons.org/licenses/by-nc-nd/2.0/fr/deed.en_GB). Pages can be printed and/or recorded in ".html".

No fees for the authors; The Atlas is in open free access for readers, and there are no fees for the authors (the opposite of "predatory open access publishing").

1st Year of Publication: 1997

Issues Frequency: Continuous online: 12 issues per year

Periodicity: The journal publishes articles online one at a time rather than collecting articles for release as an "issue". We can nonetheless determine "issues" by chronology: months and years, see http://atlasgeneticsoncology.org/Recent.html and the archives, from 1997 (vol.1), to 2017 (vol.21): http://atlasgeneticsoncology.org/DatabaseArchives/DatabaseArchives.html

Regular and stable publication: The Atlas is a regular and uninterrupted publication since 1997.

Most Recent Issue (Vol, Iss, Yr): As today, Volume 21, 2017, June issue, 9 articles, no page numbers since all online (see " 2017 - Vol 21 " i.e. http://atlasgeneticsoncology.org/DatabaseArchives/2017.html). A selection of articles published over the past few years are listed below: http://atlasgeneticsoncology.org/Tumors/GastricTumOverviewID5410.htmlhttp://atlasgeneticsoncology.org/Tumors/DuctCarcBreastID5593.htmlhttp://atlasgeneticsoncology.org/Tumors/GliomaOverviewID5763.html http://atlasgeneticsoncology.org/Tumors/OralMelanomaID6647.html http://atlasgeneticsoncology.org/Tumors/EndometStromalSarcYWHAE-NUTM2ID6649.html and recent papers: Genes: http://atlasgeneticsoncology.org/Genes/ALCAMID616ch3q13.html http://atlasgeneticsoncology.org/Genes/PGRID41700ch11q22.html http://atlasgeneticsoncology.org/Genes/WDR48ID53058ch3p22.html ; Leukemias: http://atlasgeneticsoncology.org/Anomalies/dup1qALLID1049.html http://atlasgeneticsoncology.org/Anomalies/MyeloLymphoPDGFRBID1745.html http://atlasgeneticsoncology.org/Anomalies/MixedPhenoALID1748.html ; Solid tumors: http://atlasgeneticsoncology.org/Tumors/ALKrenalCellCarcID6279.html http://atlasgeneticsoncology.org/Tumors/MaleBreastID6242.html ; Cancer-prone diseases: http://atlasgeneticsoncology.org/Kprones/DownSyndromeID10048.html ; Deep Insights: http://atlasgeneticsoncology.org/Deep/LINE1inCancerID20146.html

Database Archives: http://atlasgeneticsoncology.org/DatabaseArchives/DatabaseArchives.html

Statistic of Authors by country: http://atlasgeneticsoncology.org/Status/Status_country.html

Bibliographic records: MetaData for bibliographic records of the Atlas are at the following URL: http://atlasgeneticsoncology.org/Collab/AtlasMetadata.txt with:TITLE/DATE AUTHORS/AFFILIATION/COUNTRY/CITATION /ABSTRACT/KEYWORDS / ATLAS_ID/CLASS(Section)/URL /PUBLICATION/PUBLISHER/ISSN/LANGUAGE

III- Editorial policies

Editorial policies can be found at the following address: http://atlasgeneticsoncology.org/BackpageAuthors.htmlwith more detailed pages:

Instructions to Authors: http://documents.irevues.inist.fr/bitstream/handle/2042/48486/Instructions-to-authors.pdf

Peer Review: http://documents.irevues.inist.fr/bitstream/handle/2042/56068/Policies-editorial-ethics.pdf

Ethical Publishing Practices: http://documents.irevues.inist.fr/bitstream/handle/2042/56068/Policies-editorial-ethics.pdf

Copyright/sponsorship: http://documents.irevues.inist.fr/bitstream/handle/2042/48487/Copyright-sponsorship.pdf

Editorial content: http://atlasgeneticsoncology.org/Status/Status.html

International focus: Concerning Section Editors and Board members: http://atlasgeneticsoncology.org/BackpageAbout.html#EDITORIAL ; Concerning Authors /papers by country: http://atlasgeneticsoncology.org/Status/Status_country.html ; Concerning internauts/readers: http://chromosomesincancer.org/en/atlas-users.html

IV- Quality of its contents and editorial processes

Aims and Scope of Journal: The Atlas of Genetics and Cytogenetics in Oncology and Haematology is a journal focused on genes implicated in cancer, cytogenetics and clinical entities in cancer and cancer-prone hereditary diseases.

Content: The Atlas contains 6 sections, with articles on: 1- Genes, 2- Leukemia entities, 3- Solid tumors, 4- Cancer-prone diseases, 5- 'Deep Insights' (articles dealing with topics in areas related to core subjects in the Atlas) 6- Case reports on hematological malignancies. Papers from sections 1 to 5 are review articles, all of them are commissioned papers. Section 6, case reports, are unsolicited papers.

Number of Reviewers Assigned per Manuscript: Commissioned papers (Review articles): 2 inside reviewers; Case Reports; 1 inside + 3 to 4 outside reviewers.

Percent of Commissioned vs. Unsolicited Manuscripts: 97% (Review articles i.e. all the papers except the Case Reports) vs. 3% (Case Reports)

Acceptance Rate of Unsolicited Manuscripts in last 12 months: accepted without revision: 8%; after revision: 68%; refused: 24%.

Average Time from Acceptance of Manuscript to Publication: 2-3 weeks

Article Types Published: Reviews: about 2650 papers; Research articles: 0 (NO research papers); Case Reports: about 90 papers).

Quality of its contents/Citations: Papers published in the Atlas are cited as such in: Annual Review of Biochemistry (Impact Factor 29,88), Science (29,75), Nature Reviews Cancer (29,54), Cancer Cell (25,29), Nature Cell Biology (19,53), Journal of the National Cancer Institute (14,07), American Journal of Human Genetics (12,30), Molecular Systems Biology (12,13), Genes and Development (12,08), Genome Research (11,34), Trends in Molecular Medicine (11,05), Blood (10,56), Proceedings of the National Academy of Sciences USA (9,43), Trends in Genetics (8,69), Leukemia (8,30), Cancer Res (7,54), Nucleic Acids Research (7,48), Oncogene (7,13), … and many others.
See also the statistics of Atlas users: http://chromosomesincancer.org/en/atlas-users.html
Acknowledgements: http://chromosomesincancer.org/en/acknoledgements-to-the-atlas.html
and "Nominated for award"http://chromosomesincancer.org/en/nominated-for-an-award.html